Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

NCT02012296 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Hormone-resistant Prostate Cancer
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: enzalutamide
DRUG: mifepristone
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

University of Chicago

Collaborators

[object Object]